Bristol Myers Squibb to Participate in the 2023 UBS BioPharma Conference

Rhea-AI Summary

Bristol Myers Squibb (BMY) will participate in the 2023 UBS BioPharma Conference in Miami Beach, Florida, on November 8, 2023. Lynelle Hoch, president of the cell therapy organization, will answer questions.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the 2023 UBS BioPharma Conference in Miami Beach, Florida, on Wednesday, November 8, 2023. Lynelle Hoch, president, cell therapy organization, will answer questions about the company during a fireside chat at 8:00 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session here. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20231102123241/en/

For more information:

Media:

media@bms.com

Investors:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

What is the company participating in?

Bristol Myers Squibb is participating in the 2023 UBS BioPharma Conference.

When and where is the conference taking place?

The conference will be held in Miami Beach, Florida, on November 8, 2023.

Who will be answering questions at the conference?

Lynelle Hoch, president of the cell therapy organization at Bristol Myers Squibb, will answer questions.